Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persian herbal formulation versus sodium valproate for migraine with functional dyspepsia
IRCT20170317033107N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valproic acid and amitriptyline in migraine and functional dyspepsia (FD) (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: HIT-6 questionnaire score, Parkman criteria score and 3 more. Started Jul 2017; status: completed.
02
Drugs
valproic acidamitriptyline
03
Conditions
migrainefunctional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT20170317033107N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170317033107N3.